Germany medical cannabis market shifts to higher THC
Medical cannabis demand in Germany rises for higher-THC, lower-cost flower: median THC 23.1%→25.9%, price/gram down 31% from €8.64 to €5.95 (Dec 2024–Nov
Tag: Germany
Curaleaf Expands Medical Cannabis Presence in Germany
Curaleaf’s full Four 20 Pharma acquisition secures EU-GMP distribution in Germany. Covers medical cannabis market size, €172.5M revenue, risks and
Canadian medical cannabis at Mary Jane Berlin
medical cannabis: Canadian brands and Kootenay growers at Mary Jane Berlin 2026. 75,000 visitors, 850 exhibitors; importers link Canadian supply to Germany.
Cannabis price drop signals market maturity
cannabis price drop reshapes global markets, GCNC/Whitney Economics report says. It details pricing compression, Germany’s shift, and tactics for operators.
EU Court Shifts cannabis legalization Authority to Brussels
EU Court ruling moves cannabis legalization to EU level. Berlin leads market growth; Czech law effective Jan 1, 2026; Hungary loses Case C-271/23.
medical cannabis market shifts after German reclassification
medical cannabis market shifts in Germany after 2024 reclassification: patient trends, telemedicine use, supply pressure, reimbursement gaps, €300M swing.
Tilray launches medical cannabis brand ARX in Germany
Tilray launches ARX, its first premium medical cannabis brand in Germany, grown at Aphria RX in Neumünster with strains sourced from Canada; stock edges up.
Frankfurt Court Rules on Medical Cannabis Advertising Practices
On March 6, 2025, the Higher Regional Court of Frankfurt am Main issued a ruling related to the advertising and…
Germany’s cannabis market expected to reach $85.64 million by 2030
The German legal cannabis market is projected to grow significantly, increasing from a value of USD 37.15 million in 2024…
Bioxyne enters German medical cannabis market with $5.6M deal
Bioxyne Limited has officially entered the German medical cannabis sector through its subsidiary, Breathe Life Sciences (BLS), by securing a…